Psoriasis adverse events and associated medications as reported in the US Food and Drug Reporting System from 2016 to 2021

被引：1

作者：

Learned, Christine ^{[1
]}

Alsukait, Sara ^{[1
]}

Deverapalli, Sandhya ^{[1
]}

Elliott, Erika ^{[1
]}

Moody, Katherine ^{[1
]}

Sobell, Jeffrey ^{[1
]}

Konnikov, Nellie ^{[2
]}

Ortega, Melissa ^{[3
]}

Rosmarin, David ^{[1
]}

机构：

[1] Tufts Med Ctr, Dept Dermatol, 800 Washington Str, Boston, MA 02111 USA

[2] Boston VA Med Ctr, Dept Dermatol, Boston, MA USA

[3] Tufts Med Ctr, Dept Pharm, Boston, MA USA

来源：

JAAD INTERNATIONAL | 2022年 / 7卷

关键词：

adverse events; drug reactions; drug-induced psoriasis; immunodermatology; psoriasis;

D O I：

10.1016/j.jdin.2022.03.010

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：144 / 145

页数：2

共 50 条

[21] Review of Reported Clinical Information System Adverse Events in US Food and Drug Administration Databases
Myers, R. B.
Jones, S. L.
Sittig, D. F.
APPLIED CLINICAL INFORMATICS, 2011, 2 (01): : 63 - 74
[22] SERIOUS ADVERSE EVENTS IN NORPLANT USERS REPORTED TO THE FOOD AND DRUG ADMINISTRATIONS MEDWATCH SPONTANEOUS REPORTING SYSTEM
WYSOWSKI, DK
GREEN, L
OBSTETRICS AND GYNECOLOGY, 1995, 85 (04): : 538 - 542
[23] Hemolytic anemia following alectinib reported to the US Food and Drug Administration Adverse Event Reporting System
Dores, Graca M.
Nayernama, Afrouz
Cheng, Connie
Moureaud, Charlotte
Jones, S. Christopher
AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (04) : E129 - E132
[24] RHEUMATIC AND MUSCULOSKELETAL ADVERSE EVENTS ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS: DATA MINING OF THE US FOOD AND DRUG ADMINISTRATION ADVERSE EVENT REPORTING SYSTEM
Pundole, X.
Sarangdhar, M.
Suarez-Almazor, M. E.
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 147 - 148
[25] Infection and infestation-related adverse events of biologics in psoriasis: insights from the Food and Drug Administration Adverse Event Reporting System (FAERS)
Fang, Runan
Zhou, Yang
Han, Lu
Chen, Wenjing
Sun, Yuan
Li, Jianhong
EXPERT OPINION ON DRUG SAFETY, 2024,
[26] Dalfampridine Associated Serious Adverse Events: An Analysis of Data from the Food and Drug Administration's Adverse Event Reporting System
Ahmed, Nehad J.
Alahmari, Abdullah K.
Alshehri, Ahmed M.
Almalki, Ziyad S.
LATIN AMERICAN JOURNAL OF PHARMACY, 2022, 41 (06): : 1195 - 1199
[27] Adverse events associated with budesonide nasal irrigation reported to the US Food and Drug Administration: 2007 to 2022
Rathi, Vinay K. K.
Sawicki, Nicholas W. W.
Schlosser, Rodney J. J.
Soler, Zachary M. M.
Scangas, George A. A.
Workman, Alan D. D.
Gray, Stacey T. T.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2024, 14 (01) : 123 - 126
[28] Monitoring adverse drug events: The Food and Drug Administration MedWatch reporting system
Landow, L
REGIONAL ANESTHESIA AND PAIN MEDICINE, 1998, 23 (06): : 190 - 193
[29] Detection and analysis of signals of adverse events of memantine based on the US food and drug administration adverse event reporting system
Zhang, Weichui
Chen, Mianhai
Cai, Xiaolin
Zhang, Mengting
Hu, Mianda
Hu, Yanghui
Yang, Yurong
Zhu, Jinfeng
Du, Yikuan
Yang, Chun
EXPERT OPINION ON DRUG SAFETY, 2024, 23 (05) : 617 - 625
[30] Adverse Events Associated With Botox as Reported in a Food and Drug Administration Database
Ahsanuddin, Salma
Roy, Savannah
Nasser, Wissam
Povolotskiy, Roman
Paskhover, Boris
AESTHETIC PLASTIC SURGERY, 2021, 45 (03) : 1201 - 1209

← 1 2 3 4 5 →